You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

IODINE POVACRYLEX; ISOPROPYL ALCOHOL - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for iodine povacrylex; isopropyl alcohol and what is the scope of patent protection?

Iodine povacrylex; isopropyl alcohol is the generic ingredient in one branded drug marketed by 3M and is included in one NDA. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for IODINE POVACRYLEX; ISOPROPYL ALCOHOL
Recent Clinical Trials for IODINE POVACRYLEX; ISOPROPYL ALCOHOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, San DiegoPhase 4
University of PennsylvaniaN/A
3MN/A

See all IODINE POVACRYLEX; ISOPROPYL ALCOHOL clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for IODINE POVACRYLEX; ISOPROPYL ALCOHOL

US Patents and Regulatory Information for IODINE POVACRYLEX; ISOPROPYL ALCOHOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m DURAPREP iodine povacrylex; isopropyl alcohol SPONGE;TOPICAL 021586-001 Sep 29, 2006 OTC Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
3m DURAPREP iodine povacrylex; isopropyl alcohol SPONGE;TOPICAL 021586-002 Sep 29, 2006 OTC Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Iodine Povacrylex and Isopropyl Alcohol

Last updated: February 15, 2026

What Is the Current Market Size for Iodine Povacrylex and Isopropyl Alcohol?

Iodine Povacrylex, a povidone-iodine complex, primarily finds use as an antiseptic and disinfectant in healthcare settings. It is not a standalone drug but a component in topical antiseptics, with a global disinfectant market estimated at USD 41 billion in 2022, growing at a CAGR of 6%. The antiseptic segment, accounting for approximately 15% of that market, is driven by increased infection control measures.

Isopropyl alcohol (IPA) has a broader industrial footprint. Its global market value was USD 4.2 billion in 2021, projected to reach USD 5.4 billion by 2028, expanding at a CAGR of 3.4%. The sector's growth stems from increased demand in healthcare, disinfectant manufacturing, and consumer products, particularly amid heightened hygiene protocols following the COVID-19 pandemic.

How Do Regulatory Approvals Affect Market Potential?

Both compounds are approved for specific medical and industrial uses. Iodine Povacrylex, registered as an antiseptic in multiple jurisdictions, faces regulatory barriers concerning safety and efficacy evidence. Its use is confined to topical applications with approved formulations.

Isopropyl alcohol is designated as a solvent and disinfectant with established safety profiles. Regulatory agencies like the U.S. FDA and EMA approve manufacturing processes and labeling but generally do not restrict use in disinfectant products. Emerging regulatory trends favor increased oversight of hand sanitizers and surface disinfectants, potentially influencing IPA's market valuation.

What Are Key Drivers Shaping Future Demand?

For Iodine Povacrylex:

  • Rising hospital-acquired infection (HAI) rates and emphasis on infection prevention measures.
  • Growing demand for broad-spectrum antiseptics in surgical preparation.
  • Shift toward multi-use antiseptic products driven by healthcare policies.

For Isopropyl Alcohol:

  • Continued expansion of disinfectant products in healthcare, food service, and consumer sectors.
  • Implementation of stringent hygiene protocols during ongoing and future pandemics.
  • Increasing demand for alcohol-based hand sanitizers and surface disinfectants.

Which Factors Might Impede Market Growth?

For Iodine Povacrylex:

  • Antiseptic resistance and hypersensitivity concerns limit long-term utility.
  • Competition from alternative disinfectants such as chlorhexidine and ethanol-based solutions.
  • Regulatory hurdles in expanding indications.

For Isopropyl Alcohol:

  • Price fluctuations driven by raw material availability (e.g., propylene and acetone).
  • Environmental and safety regulations restricting manufacturing processes.
  • Market saturation in mature regions prompting slow growth.

What Are Financial Trends and Investment Opportunities?

Investments focus on manufacturing capacity expansion, especially amid increased demand for disinfectants. Several companies have announced capacity upgrades:

  • Kroger announced a USD 200 million investment in hand sanitizer production lines in 2021.
  • Koss Corp. expanded IPA capacity, targeting a 25% increase over 2022 levels.
  • New entrants are exploring production in regions such as Asia-Pacific, where demand growth outpaces global averages.

Pricing trends for IPA spiked during COVID-19, with domestic prices in the U.S. reaching USD 2.50 per liter in 2020, then stabilizing around USD 1.80 in 2022. Iodine-based antiseptics saw stable pricing, but volume demand varies with infection control needs.

What Are Strategic Considerations for Stakeholders?

Suppliers should monitor regulatory developments and raw material costs, particularly in regions with environmental restrictions. R&D efforts should target alternative formulations with enhanced safety profiles or spectrum of activity. Companies investing in capacity expansion may see accelerated revenue growth, especially if global health emergencies persist.

Healthcare providers and policymakers influence market direction through infection control standards, incentivizing the adoption of cost-effective, proven antiseptics and disinfectants.

How Do Competitive Landscapes Look?

Major players include:

  • For Iodine Povacrylex: HC Company, SafeDisinfect Inc., and MedBio Ltd.
  • For Isopropyl Alcohol: BASF SE, Shell, ExxonMobil, and global generic manufacturers.

Innovations focus on formulation stability, reduced skin irritation, and eco-friendly manufacturing. There is a trend toward combining IPA with other active ingredients for broader antimicrobial activity.

What Are the Key Risks and Opportunities?

Risks:

  • Potential regulatory bans on certain disinfectants.
  • Raw material price volatility.
  • Competitive pressure from new disinfectant technologies.

Opportunities:

  • Growing demand for long-lasting antiseptics.
  • Market expansion in emerging economies.
  • Development of eco-friendly variants aligning with environmental policies.

Key Takeaways

  • Market sizes: USD 41 billion for disinfectants (including povidone-iodine), USD 4.2 billion for IPA.
  • Growth drivers: Infection control, pandemic response, hygiene trends.
  • Regulatory landscape: Approvals stable but evolving, impacting innovation and pricing.
  • Investment focus: Capacity expansion, product innovation, and regional diversification.
  • Risks: Raw material costs, regulatory restrictions, market saturation.

FAQs

1. How resilient are these markets to global health crises?
Both markets expand during pandemics, driven by increased hygiene needs. Disinfectant demand tends to spike sharply and may decline post-crisis, but long-term growth persists.

2. Are there significant substitutes for Iodine Povacrylex?
Yes. Alternatives include chlorhexidine, alcohol-based solutions, and hydrogen peroxide. These may limit Iodine Povacrylex's market share when substitutes are preferred for safety or cost reasons.

3. What regions offer the highest growth prospects?
Emerging markets in Asia-Pacific and Latin America show higher growth rates due to rising healthcare infrastructure and hygiene awareness.

4. How do raw material price fluctuations impact profitability?
Price volatility, especially in propylene and acetone for IPA, can affect margins. Strategic sourcing and diversification mitigate risks.

5. What are the prospects for new formulations?
Product innovation, such as reduced skin irritation or environmental friendliness, can open new market segments and preserve competitive positioning.


Sources:
[1] MarketsandMarkets. Disinfectants Market, 2022.
[2] Grand View Research. Isopropyl Alcohol Market Forecast, 2021-2028.
[3] CDC. Infection Control Guidelines, 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.